Cay, F. Et Al. 2006. The clinical significance of serum levels anti-CCP and peptidyl arginine deiminase (PAD) activity in leucocytes of patients with rheumatoid arthritis. Annual European Congress of Rheumatology (EULAR 2006) , (Amsterdam, Netherlands), 127.

Cay, F., Yurdakonar, E., Caglar, S., KAÇAR, C., TUNCER, T., & Yucel, G., (2006). The clinical significance of serum levels anti-CCP and peptidyl arginine deiminase (PAD) activity in leucocytes of patients with rheumatoid arthritis . Annual European Congress of Rheumatology (EULAR 2006) (pp.127). Amsterdam, Netherlands

Cay, F. Et Al. "The clinical significance of serum levels anti-CCP and peptidyl arginine deiminase (PAD) activity in leucocytes of patients with rheumatoid arthritis," Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Netherlands, 2006

Cay, F. Et Al. "The clinical significance of serum levels anti-CCP and peptidyl arginine deiminase (PAD) activity in leucocytes of patients with rheumatoid arthritis." Annual European Congress of Rheumatology (EULAR 2006) , Amsterdam, Netherlands, pp.127, 2006

Cay, F. Et Al. (2006) . "The clinical significance of serum levels anti-CCP and peptidyl arginine deiminase (PAD) activity in leucocytes of patients with rheumatoid arthritis." Annual European Congress of Rheumatology (EULAR 2006) , Amsterdam, Netherlands, p.127.

@conferencepaper{conferencepaper, author={F. Cay Et Al. }, title={The clinical significance of serum levels anti-CCP and peptidyl arginine deiminase (PAD) activity in leucocytes of patients with rheumatoid arthritis}, congress name={Annual European Congress of Rheumatology (EULAR 2006)}, city={Amsterdam}, country={Netherlands}, year={2006}, pages={127} }